Cernackova Alena, Tillinger Andrej, Bizik Jozef, Mravec Boris, Horvathova Lubica
Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia; Institute of Physiology, Faculty of Medicine, Comenius University in Bratislava, Slovakia; Department of Biological and Medical Sciences, Faculty of Physical Education and Sports, Comenius University in Bratislava, Slovakia.
Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
J Neuroimmunol. 2023 Mar 15;376:578033. doi: 10.1016/j.jneuroim.2023.578033. Epub 2023 Jan 21.
Accumulated data indicate that inflammation affecting brain structures participates in the development of cancer-related cachexia. However, the mechanisms responsible for the induction and progression of cancer-related neuroinflammation are still not fully understood. Therefore, we studied the time-course of neuroinflammation in selected brain structures and cachexia development in tumor-bearing rats. After tumor cells inoculation, specifically on the 7th, 14th, 21st, and 28th day of tumor growth, we assessed the presence of cancer-associated cachexia in rats. Changes in gene expression of inflammatory factors were studied in selected regions of the hypothalamus, brain stem, and circumventricular organs. We showed that the initial stages of cancer growth (7th and 14th day after tumor cells inoculation), are not associated with cachexia, or increased expression of inflammatory molecules in the brain. Even when we did not detect cachexia in tumor-bearing rats by the 21st day of the experiment, the inflammatory brain reaction had already started, as we found elevated levels of interleukin 1 beta, interleukin 6, tumor necrosis factor alpha, and glial fibrillary acidic protein mRNA levels in the nucleus of the solitary tract. Furthermore, we found increased interleukin 1 beta expression in the locus coeruleus and higher allograft inflammatory factor 1 expression in the vascular organ of lamina terminalis. Ultimately, the most pronounced manifestations of tumor growth were present on the 28th day post-inoculation of tumor cells. In these animals, we detected cancer-related cachexia and significant increases in interleukin 1 beta expression in all brain areas studied. We also observed significantly decreased expression of the glial cell activation markers allograft inflammatory factor 1 and glial fibrillary acidic protein in most brain areas of cachectic rats. In addition, we showed increased expression of cluster of differentiation 163 and cyclooxygenase 2 mRNA in the hypothalamic paraventricular nucleus, A1/C1 neurons, and area postrema of cachectic rats. Our data indicate that cancer-related cachexia is associated with complex neuroinflammatory changes in the brain. These changes can be found in both hypothalamic as well as extrahypothalamic structures, while their extent and character depend on the stage of tumor growth.
累积数据表明,影响脑结构的炎症参与了癌症相关性恶病质的发展。然而,导致癌症相关性神经炎症诱导和进展的机制仍未完全明确。因此,我们研究了荷瘤大鼠特定脑结构中神经炎症的时间进程以及恶病质的发展情况。在接种肿瘤细胞后,特别是在肿瘤生长的第7天、14天、21天和28天,我们评估了大鼠中癌症相关性恶病质的存在情况。在丘脑下部、脑干和室周器官的选定区域研究了炎症因子基因表达的变化。我们发现,肿瘤生长的初始阶段(接种肿瘤细胞后的第7天和14天)与恶病质或脑中炎症分子表达增加无关。即使在实验的第21天我们未在荷瘤大鼠中检测到恶病质,但脑炎症反应已经开始,因为我们在孤束核中发现白细胞介素1β、白细胞介素6、肿瘤坏死因子α和胶质纤维酸性蛋白mRNA水平升高。此外,我们发现蓝斑中白细胞介素1β表达增加,终板血管器中同种异体移植炎症因子1表达更高。最终,接种肿瘤细胞后第28天出现了最明显的肿瘤生长表现。在这些动物中,我们检测到癌症相关性恶病质,并且在所研究的所有脑区中白细胞介素1β表达显著增加。我们还观察到,恶病质大鼠的大多数脑区中胶质细胞活化标志物同种异体移植炎症因子1和胶质纤维酸性蛋白的表达显著降低。此外,我们发现恶病质大鼠的下丘脑室旁核、A1/C1神经元和最后区中分化簇163和环氧化酶2 mRNA表达增加。我们的数据表明,癌症相关性恶病质与脑中复杂的神经炎症变化相关。这些变化在下丘脑以及下丘脑外结构中均能发现,而它们的程度和特征取决于肿瘤生长阶段。